Preserving Patient Access to Long-Term Care Pharmacies Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Requires Medicare Part D and Medicare Advantage prescription drug plan sponsors to pay long-term care pharmacies a separate supply fee for certain prescriptions in plan years 2026 and 2027.
Who Benefits and How
Long-term care pharmacies could receive a new mandatory payment on top of other reimbursement for specified prescriptions.
Who Bears the Burden and How
Part D sponsors and Medicare Advantage prescription drug plans would face additional payment obligations and possible civil penalties for nonpayment.
Key Provisions
- Requires a $30 supply fee in 2026 for each specified prescription dispensed by a long-term care pharmacy and indexes the fee in 2027.
- Requires the fee to be paid in addition to other negotiated pharmacy reimbursements.
- Imposes civil money penalties for plans that fail to pay the fee.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires Medicare Part D and Medicare Advantage prescription drug plan sponsors to pay long-term care pharmacies a separate supply fee for certain prescriptions in plan years 2026 and 2027.
Key Policy Areas
Health Care
Primary Purpose
Requires Medicare Part D and Medicare Advantage prescription drug plan sponsors to pay long-term care pharmacies a separate supply fee for certain prescriptions in plan years 2026 and 2027.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Long-term care pharmacies dispensing specified prescriptions
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Prescription drug plan sponsors and Medicare Advantage organizations required to pay the fee
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Lankford (for himself and Mr. Mullin) introduced the following …
Read twice and referred to the Committee on Finance.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Long-term care pharmacies dispensing specified prescriptions, Prescription drug plan sponsors and Medicare Advantage organizations paying the supply fee
Positive-direction: Long-term care pharmacies dispensing specified prescriptions
Negative-direction: Prescription drug plan sponsors and Medicare Advantage organizations paying the supply fee
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology